Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03BNF
|
|||
| Drug Name |
IMGN632
|
|||
| Indication | Blastic plasmacytoid dendritic cell neoplasm [ICD-11: 2A60.5; ICD-10: C86.4] | Phase 1/2 | [1] | |
| Company |
ImmunoGen Waltham, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03386513) Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.